vs

Side-by-side financial comparison of Ceribell, Inc. (CBLL) and SMITH MIDLAND CORP (SMID). Click either name above to swap in a different company.

Ceribell, Inc. is the larger business by last-quarter revenue ($24.8M vs $23.1M, roughly 1.1× SMITH MIDLAND CORP). SMITH MIDLAND CORP runs the higher net margin — 9.2% vs -54.6%, a 63.8% gap on every dollar of revenue.

Ceribell, Inc. develops and commercializes innovative portable neurodiagnostic medical devices, focused on rapid non-invasive electroencephalogram (EEG) solutions for seizure detection. Its core products serve hospital emergency departments, intensive care units, and long-term care facilities, with primary markets across North America and ongoing global expansion efforts.

Smith Midland Corp is a specialized manufacturer of precast concrete products for infrastructure, commercial, residential and industrial construction uses. Its key product lines include highway safety barriers, acoustic sound walls, architectural precast panels, and stormwater management systems, serving primarily the North American market with durable, sustainable construction solutions.

CBLL vs SMID — Head-to-Head

Bigger by revenue
CBLL
CBLL
1.1× larger
CBLL
$24.8M
$23.1M
SMID
Higher net margin
SMID
SMID
63.8% more per $
SMID
9.2%
-54.6%
CBLL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CBLL
CBLL
SMID
SMID
Revenue
$24.8M
$23.1M
Net Profit
$-13.5M
$2.1M
Gross Margin
87.3%
57.5%
Operating Margin
-58.9%
37.8%
Net Margin
-54.6%
9.2%
Revenue YoY
24.7%
Net Profit YoY
52.5%
EPS (diluted)
$-0.35
$0.41

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBLL
CBLL
SMID
SMID
Q4 25
$24.8M
$23.1M
Q3 25
$22.6M
$21.5M
Q2 25
$21.2M
$26.2M
Q1 25
$20.5M
$22.7M
Q4 24
$18.5M
Q3 24
$17.2M
$23.6M
Q2 24
$19.6M
Q1 24
$16.8M
Net Profit
CBLL
CBLL
SMID
SMID
Q4 25
$-13.5M
$2.1M
Q3 25
$-13.5M
$2.9M
Q2 25
$-13.6M
$4.2M
Q1 25
$-12.8M
$3.3M
Q4 24
$1.4M
Q3 24
$-10.4M
$3.1M
Q2 24
$2.0M
Q1 24
$1.1M
Gross Margin
CBLL
CBLL
SMID
SMID
Q4 25
87.3%
57.5%
Q3 25
88.3%
26.8%
Q2 25
88.1%
0.0%
Q1 25
87.9%
30.7%
Q4 24
51.4%
Q3 24
87.3%
27.9%
Q2 24
0.0%
Q1 24
23.3%
Operating Margin
CBLL
CBLL
SMID
SMID
Q4 25
-58.9%
37.8%
Q3 25
-64.8%
18.0%
Q2 25
-70.5%
0.0%
Q1 25
-69.3%
19.3%
Q4 24
24.5%
Q3 24
-57.8%
16.3%
Q2 24
0.0%
Q1 24
9.0%
Net Margin
CBLL
CBLL
SMID
SMID
Q4 25
-54.6%
9.2%
Q3 25
-59.6%
13.4%
Q2 25
-64.4%
15.9%
Q1 25
-62.4%
14.7%
Q4 24
7.5%
Q3 24
-60.6%
13.4%
Q2 24
10.1%
Q1 24
6.8%
EPS (diluted)
CBLL
CBLL
SMID
SMID
Q4 25
$-0.35
$0.41
Q3 25
$-0.37
$0.54
Q2 25
$-0.38
$0.79
Q1 25
$-0.36
$0.62
Q4 24
$0.28
Q3 24
$-1.85
$0.59
Q2 24
$0.37
Q1 24
$0.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBLL
CBLL
SMID
SMID
Cash + ST InvestmentsLiquidity on hand
$159.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$155.3M
$54.3M
Total Assets
$195.8M
$87.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBLL
CBLL
SMID
SMID
Q4 25
$159.3M
Q3 25
$168.5M
Q2 25
$177.4M
Q1 25
$182.7M
Q4 24
Q3 24
$14.1M
Q2 24
Q1 24
Stockholders' Equity
CBLL
CBLL
SMID
SMID
Q4 25
$155.3M
$54.3M
Q3 25
$164.1M
$52.1M
Q2 25
$172.2M
$49.2M
Q1 25
$180.9M
$45.1M
Q4 24
$41.7M
Q3 24
$-136.0M
$40.3M
Q2 24
$37.2M
Q1 24
$35.3M
Total Assets
CBLL
CBLL
SMID
SMID
Q4 25
$195.8M
$87.7M
Q3 25
$199.5M
$85.4M
Q2 25
$207.7M
$81.2K
Q1 25
$213.5M
$74.7M
Q4 24
$68.0M
Q3 24
$47.1M
$66.6M
Q2 24
$64.0M
Q1 24
$64.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CBLL
CBLL
SMID
SMID
Operating Cash FlowLast quarter
$-10.8M
Free Cash FlowOCF − Capex
$-11.0M
FCF MarginFCF / Revenue
-44.2%
Capex IntensityCapex / Revenue
0.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-41.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CBLL
CBLL
SMID
SMID
Q4 25
$-10.8M
Q3 25
$-11.1M
$11.7M
Q2 25
$-7.5M
Q1 25
$-11.4M
$2.2M
Q4 24
$-645.0K
Q3 24
$3.9M
Q2 24
$2.7M
Q1 24
$-777.0K
Free Cash Flow
CBLL
CBLL
SMID
SMID
Q4 25
$-11.0M
Q3 25
$-11.5M
$6.3M
Q2 25
$-7.6M
Q1 25
$-11.6M
$1.6M
Q4 24
$-1.3M
Q3 24
$1.8M
Q2 24
$998.0K
Q1 24
$-2.6M
FCF Margin
CBLL
CBLL
SMID
SMID
Q4 25
-44.2%
Q3 25
-50.8%
29.5%
Q2 25
-35.9%
Q1 25
-56.4%
7.1%
Q4 24
-7.0%
Q3 24
7.8%
Q2 24
5.1%
Q1 24
-15.3%
Capex Intensity
CBLL
CBLL
SMID
SMID
Q4 25
0.7%
Q3 25
1.6%
25.1%
Q2 25
0.3%
Q1 25
0.7%
2.6%
Q4 24
3.6%
Q3 24
8.6%
Q2 24
8.7%
Q1 24
10.7%
Cash Conversion
CBLL
CBLL
SMID
SMID
Q4 25
Q3 25
4.07×
Q2 25
Q1 25
0.67×
Q4 24
-0.46×
Q3 24
1.23×
Q2 24
1.37×
Q1 24
-0.68×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CBLL
CBLL

Products$18.8M76%
Subscription$6.0M24%

SMID
SMID

Product Sales$13.8M60%
Service Revenue$9.3M40%

Related Comparisons